A股異動丨龍大肉食漲停 農發行出台專項政策大力支持生豬生產
格隆匯3月5日丨龍大肉食(002726.SZ)漲停,報7.18元,總市值71.7億元。農發行出台《關於進一步加大生豬生產信貸支持力度的通知》,進一步明確支持生豬產業發展的工作要求和差異化信貸政策,全力支持生豬產業儘快恢復生產。《通知》提出,農發行2020年全行生豬產業貸款新增100億元以上,力爭在6月底前完成全年任務,並對各省級分行任務完成情況進行考核。龍大肉食主營業務為生豬養殖、生豬屠宰和肉製品加工。公司主要產品為商品豬、冷鮮豬肉、冷凍豬肉及肉製品。經過多年發展,公司已形成集種豬繁育、飼料生產、生豬養殖、屠宰分割、肉製品加工、食品檢驗、銷售渠道建設為一體的“全產業鏈”經營發展模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.